Switching to an alternative biological agent in juvenile idiopathic arthritis (I)

Por Gonzalez MI, Murias S, Remesal A, Tarjuelo I, Merino R
Publicado em 2011-09-01

Switching to an alternative biological agent in juvenile idiopathic arthritis (I)

Por Remesal, A, Murias, S, Gonzalez, MI, Tarjuelo, I, Merino, R
Publicado em 2011

Switching to an alternative biological agent in juvenile idiopathic arthritis (II)

Por Murias, S, Remesal, A, Latorre, L, Gomez, M, Merino, R
Publicado em 2011

A family carrying a homozygous LACC1 truncated mutation expands the clinical phenotype of this disease beyond systemic-onset juvenile idiopathic arthritis

Por Arostegui, JI, Rabionet, R, Remesal, A, Mensa-Vilaro, A, Murias, S, Alcobendas, R, Gonzalez-Roca, E, Dreschsel, O, Ruiz-Ortiz, E, Puig, A, Comas, D, Ossowski, S, Yagüe, J, Estivill, X, Merino, R
Publicado no Pediatr Rheumatol Online J (2015)